Enablers and Barriers to the Scaling Up of Pneumococcal Conjugate Vaccine in India During the COVID-19 Pandemic: A Qualitative Study

Enablers and Barriers to the Scaling Up of Pneumococcal Conjugate Vaccine in India During the COVID-19 Pandemic: A Qualitative Study

Background: Pneumonia is one of the leading causes of death in under-5 children in India. This led the Ministry of Health & Family Welfare (MoHFW) in India to decide for the nationwide roll-out of the Pneumococcal Conjugate Vaccine (PCV). However, the introduction of PCV became more complex in t...

Full description

Bibliographic Details
Main Authors:	Rhythm Hora, Arindam Ray, Rashmi Mehra, Tanwi Priya, Seema Singh Koshal, Pankaj Agrawal, Amanjot Kaur, Syed F Quadri, Arup Deb Roy
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-07-01
Series:	Health Services Insights
Online Access:	https://doi.org/10.1177/11786329231189407

Similar Items

Critical factors in the successful expansion of Pneumococcal Conjugate Vaccine in India during the COVID-19 pandemic
by: Seema Singh Koshal, et al.
Published: (2023-08-01)

Enablers and barriers to rotavirus vaccine coverage in Assam, India- A qualitative study
by: Rashmi Mehra, et al.
Published: (2024-06-01)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
by: Shamez N. Ladhani, et al.
Published: (2013-01-01)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
by: Edmunds W John, et al.
Published: (2010-04-01)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Anna M.M. van Deursen, et al.
Published: (2012-11-01)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
by: Bhavna Dhingra, et al.
Published: (2020-12-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
by: Adamu, AL, et al.
Published: (2023)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2021-10-01)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
by: Aishatu L. Adamu, et al.
Published: (2023-05-01)

Nasopharyngeal Pneumococcal Colonization among Children after Pneumococcal Conjugate Vaccine Introduction
by: Manoochehr Karami, et al.
Published: (2017-08-01)

Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine.
by: Jennifer C Moïsi, et al.
Published: (2017-01-01)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
by: Grant A. Mackenzie, et al.
Published: (2022-01-01)

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
by: Godwin Oligbu, et al.
Published: (2019-09-01)

Barriers to pneumococcal conjugate 13 vaccination recommendations among physicians in Lagos
by: oluwafemi ojo
Published: (2022-06-01)

Incidence of pneumonia is not reduced by pneumococcal conjugate vaccine
by: Sona Chowdhary, et al.
Published: (2008-10-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

Economic evaluation of pneumococcal conjugate vaccination in The Gambia
by: Kim Sun-Young, et al.
Published: (2010-09-01)

Herd protection induced by pneumococcal conjugate vaccine
by: Keith P Klugman
Published: (2014-07-01)

13-valent pneumococcal conjugate vaccine in Africa
by: Robert Cohen, et al.
Published: (2017-03-01)

Conjugate pneumococcal vaccines: Need and choice in India
by: Akash Malik, et al.
Published: (2013-01-01)

Genetic background of Cambodian pneumococcal carriage isolates following pneumococcal conjugate vaccine 13
by: Belman, S, et al.
Published: (2022)

Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age
by: Raul E. Isturiz, et al.
Published: (2018-01-01)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
by: Ahmet Arvas, et al.
Published: (2017-08-01)

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
by: von Kries Rüdiger, et al.
Published: (2010-01-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
by: Carina Valente, et al.
Published: (2012-01-01)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
by: Thijs W. Hoffman, MD, et al.
Published: (2020-06-01)

State of the globe: Effect of pneumococcal conjugate vaccines on nonvaccine-type invasive pneumococcal disease
by: Sunil Kumar Raina
Published: (2019-01-01)

Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil.
by: Ana Lucia Andrade, et al.
Published: (2014-01-01)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
by: George Gourzoulidis, et al.
Published: (2023-09-01)

Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
by: Michael Pichichero, et al.
Published: (2023-12-01)

Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2024-02-01)

PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
by: Timothy J Chapman, et al.
Published: (2024-12-01)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
by: Chiara Scelfo, et al.
Published: (2021-04-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
by: Sweta M. Patel, et al.
Published: (2022-01-01)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan
by: Hsiao-Chun Chi, et al.
Published: (2018-06-01)

Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
by: Paul Turner, et al.
Published: (2015-11-01)

Pneumococcal conjugate vaccine implementation in middle-income countries
by: Tricarico, Serena, et al.
Published: (2017)